Related Experiment Video

Updated: Jul 18, 2026

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease
06:25

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

Published on: March 29, 2024

The Src signaling pathway: a potential target in melanoma and other malignancies

Jade Homsi1, Christopher Cubitt, Adil Daud

  • 1Cutaneous Therapeutic Program, H Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL, USA.

Expert Opinion on Therapeutic Targets
|December 8, 2006
PubMed

Insights

Src signaling plays a key role in melanoma progression by regulating cell motility and invasiveness. Targeting Src kinase activity offers a promising therapeutic strategy for melanoma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Src, the first discovered oncogene, and its family kinases are implicated in human oncogenesis.
  • Src influences cancer cell adhesion, invasiveness, and motility, rather than directly affecting cell replication.
  • Elevated Src kinase activity is observed in various human cancers, including melanoma.

Purpose of the Study:

  • To investigate the role of Src signaling in melanoma.
  • To evaluate Src and STAT3 activation in human melanoma.
  • To identify Src signaling as a potential therapeutic target in melanoma.

Main Methods:

  • Analysis of Src expression and activity in melanoma cell lines and tumors.
  • Investigation of Src-mediated activation of downstream targets like STAT3 and STAT5 in melanoma.
  • In vitro and in vivo studies examining Src kinase activity in human melanoma samples.

Main Results:

  • Increased Src expression and activity were detected in melanoma cell lines and tumors.
  • Src activation of STAT3 and STAT5 was observed in melanoma.
  • Activated forms of Src and STAT3 were present in both primary and metastatic human melanoma, with variable expression levels.

Conclusions:

  • Src signaling is crucial for melanoma progression and metastasis.
  • Activated Src and STAT3 pathways are key features of human melanoma.
  • Src signaling represents an attractive therapeutic target for melanoma treatment, with ongoing development of novel Src inhibitors.

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...